ResMed Inc. logo
RMDResMed Inc.

EV/Assets Ratio: 3.23x

Is the EV/Assets ratio high or low?

The EV/Assets ratio of 3.23x is 40% below its 5-year average of 5.42x, near the low end of its 5-year range (2.97x–9.32x).

As of Friday, June 26, 2026. 25.65% below its 12-month average of 4.34x.

RMD EV/Assets Ratio

RMD EV/Assets Ratio Chart

3.23x
-35.53% 1Y
RMD EV/Assets Ratio

RMD Average EV/Assets Ratio Chart

RMD EV/Assets Ratio

RMD Current vs Average EV/Assets Ratio Chart

RMD EV/Assets Ratio Metrics

EV/ASSETS RATIO

3.23x

EV/ASSETS RATIO AVG TTM

4.34x

EV/ASSETS RATIO AVG 3Y

4.44x

EV/ASSETS RATIO AVG 5Y

5.42x

EV/ASSETS RATIO AVG 10Y

4.97x

EV/ASSETS RATIO AVG 15Y

4.22x

EV/ASSETS RATIO AVG 20Y

3.79x

CURRENT VS TTM AVG

-25.65%

CURRENT VS 3Y AVG

-27.26%

CURRENT VS 5Y AVG

-40.42%

CURRENT VS 10Y AVG

-35.06%

CURRENT VS 15Y AVG

-23.51%

CURRENT VS 20Y AVG

-14.77%

RMD Competitors' EV/Assets Ratio

NAMEMARKET CAPEV/ASSETS RATIOTTM3Y5Y
ResMed Inc. (RMD)$28.81B3.23x4.34x4.44x5.42x
DexCom, Inc. (DXCM)vs ›$26.82B4.11x4.19x5.81x7.42x
Moderna, Inc. (MRNA)vs ›$26.45B2.00x1.19x1.48x2.49x
Biogen Inc. (BIIB)vs ›$31.51B1.12x0.97x1.18x1.41x
IQVIA Holdings Inc. (IQV)vs ›$31.58B1.54x1.61x1.82x1.99x
Veeva Systems Inc. (VEEV)vs ›$25.68B2.68x4.51x5.28x6.88x
Medline Inc. (MDLN)vs ›$31.94B1.07x1.16x1.16x1.16x
Zoetis Inc. (ZTS)vs ›$32.06B2.65x4.15x5.39x5.80x
Centene Corp. (CNC)vs ›$32.31B0.27x0.36x0.49x0.55x
Mettler-Toledo International Inc. (MTD)vs ›$25.24B7.47x8.22x8.60x9.30x

EV/Assets Ratio Formula & Definition

EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/Assets Ratio FAQ

What is the EV/Assets ratio for ResMed Inc. (RMD)?
The EV/Assets ratio for RMD stock is 3.23x.
Is ResMed Inc.'s EV/Assets ratio high or low?
The EV/Assets ratio of 3.23x is 40% below its 5-year average of 5.42x, near the low end of its 5-year range (2.97x–9.32x).
What is the TTM average EV/Assets ratio for ResMed Inc. (RMD)?
The TTM average EV/Assets ratio for RMD stock is 4.34x.
What is the 3Y average EV/Assets ratio for ResMed Inc. (RMD)?
The 3Y average EV/Assets ratio for RMD stock is 4.44x.
What is the 5Y average EV/Assets ratio for ResMed Inc. (RMD)?
The 5Y average EV/Assets ratio for RMD stock is 5.42x.
What is the 10Y average EV/Assets ratio for ResMed Inc. (RMD)?
The 10Y average EV/Assets ratio for RMD stock is 4.97x.
What is the 15Y average EV/Assets ratio for ResMed Inc. (RMD)?
The 15Y average EV/Assets ratio for RMD stock is 4.22x.
What is the 20Y average EV/Assets ratio for ResMed Inc. (RMD)?
The 20Y average EV/Assets ratio for RMD stock is 3.79x.

RMD EV/Assets Ratio History

DATEEV/ASSETS RATIO
2026-06-253.23x
2026-06-243.20x
2026-06-233.11x
2026-06-223.06x
2026-06-183.06x
2026-06-173.03x
2026-06-163.15x
2026-06-153.13x
2026-06-123.17x
2026-06-113.13x
2026-06-103.15x
2026-06-093.20x
2026-06-083.14x
2026-06-053.19x
2026-06-043.16x
2026-06-033.03x
2026-06-022.97x
2026-06-013.03x
2026-05-293.10x
2026-05-283.31x
2026-05-273.36x
2026-05-263.39x
2026-05-223.39x
2026-05-213.40x
2026-05-203.42x
2026-05-193.38x
2026-05-183.32x
2026-05-153.29x
2026-05-143.30x
2026-05-133.29x
2026-05-123.32x
2026-05-113.23x
2026-05-083.37x
2026-05-073.37x
2026-05-063.42x
2026-05-053.39x
2026-05-043.41x
2026-05-013.34x
2026-04-303.49x
2026-04-293.62x
2026-04-283.71x
2026-04-273.79x
2026-04-243.75x
2026-04-233.75x
2026-04-223.79x
2026-04-213.78x
2026-04-203.86x
2026-04-173.90x
2026-04-163.84x
2026-04-153.91x
2026-04-143.94x
2026-04-133.93x
2026-04-103.91x
2026-04-093.89x
2026-04-083.94x
2026-04-073.86x
2026-04-063.84x
2026-04-023.83x
2026-04-013.80x
2026-03-313.83x
2026-03-303.76x
2026-03-273.76x
2026-03-263.80x
2026-03-253.86x
2026-03-243.90x
2026-03-233.89x
2026-03-203.86x
2026-03-193.88x
2026-03-183.89x
2026-03-173.99x
2026-03-163.94x
2026-03-133.94x
2026-03-123.97x
2026-03-114.10x
2026-03-104.22x
2026-03-094.32x
2026-03-064.32x
2026-03-054.37x
2026-03-044.43x
2026-03-034.42x
2026-03-024.40x
2026-02-274.38x
2026-02-264.40x
2026-02-254.32x
2026-02-244.30x
2026-02-234.46x
2026-02-204.43x
2026-02-194.38x
2026-02-184.43x
2026-02-174.37x
2026-02-134.32x
2026-02-124.20x
2026-02-114.44x
2026-02-104.51x
2026-02-094.72x
2026-02-064.65x
2026-02-054.57x
2026-02-044.50x
2026-02-034.30x
2026-02-024.36x
2026-01-304.42x
2026-01-294.41x
2026-01-284.50x
2026-01-274.46x
2026-01-264.46x
2026-01-234.40x
2026-01-224.45x
2026-01-214.52x
2026-01-204.42x
2026-01-164.49x
2026-01-154.55x
2026-01-144.53x
2026-01-134.44x
2026-01-124.50x
2026-01-094.40x
2026-01-084.38x
2026-01-074.33x
2026-01-064.35x
2026-01-054.28x
2026-01-024.27x
2025-12-314.20x
2025-12-304.24x
2025-12-294.23x
2025-12-264.27x
2025-12-244.26x
2025-12-234.26x
2025-12-224.30x
2025-12-194.27x
2025-12-184.23x
2025-12-174.29x
2025-12-164.31x
2025-12-154.41x
2025-12-124.40x
2025-12-114.40x
2025-12-104.39x
2025-12-094.30x
2025-12-084.36x
2025-12-054.48x
2025-12-044.39x
2025-12-034.39x
2025-12-024.37x
2025-12-014.33x
2025-11-284.46x
2025-11-264.45x
2025-11-254.46x
2025-11-244.37x
2025-11-214.37x
2025-11-204.25x
2025-11-194.27x
2025-11-184.29x
2025-11-174.27x
2025-11-144.26x
2025-11-134.40x
2025-11-124.41x
2025-11-114.40x
2025-11-104.36x
2025-11-074.39x
2025-11-064.35x
2025-11-054.28x
2025-11-044.30x
2025-11-034.34x
2025-10-314.30x
2025-10-304.40x
2025-10-294.52x
2025-10-284.57x
2025-10-274.62x
2025-10-244.62x
2025-10-234.73x
2025-10-224.75x
2025-10-214.78x
2025-10-204.84x
2025-10-174.78x
2025-10-164.81x
2025-10-154.81x
2025-10-144.81x
2025-10-134.87x
2025-10-104.85x
2025-10-094.95x
2025-10-085.04x
2025-10-075.05x
2025-10-065.02x
2025-10-034.97x
2025-10-024.93x
2025-10-014.83x
2025-09-304.88x
2025-09-294.83x
2025-09-264.82x
2025-09-254.76x
2025-09-244.89x
2025-09-234.91x
2025-09-224.89x
2025-09-194.87x
2025-09-184.87x
2025-09-174.84x
2025-09-164.86x
2025-09-154.83x
2025-09-124.82x
2025-09-114.90x
2025-09-104.82x
2025-09-094.98x
2025-09-084.98x
2025-09-054.94x
2025-09-044.88x
2025-09-034.80x
2025-09-024.83x
2025-08-294.89x
2025-08-284.91x
2025-08-275.03x
2025-08-265.09x
2025-08-255.10x
2025-08-225.24x
2025-08-215.14x
2025-08-205.16x
2025-08-195.10x
2025-08-185.10x
2025-08-155.08x
2025-08-145.08x
2025-08-135.14x
2025-08-125.05x
2025-08-115.07x
2025-08-085.06x
2025-08-075.00x
2025-08-065.44x
2025-08-055.53x
2025-08-045.66x
2025-08-015.42x
2025-07-315.28x
2025-07-305.39x
2025-07-295.39x
2025-07-285.31x
2025-07-255.34x
2025-07-245.31x
2025-07-235.31x
2025-07-225.19x
2025-07-215.07x
2025-07-185.01x
2025-07-174.98x
2025-07-164.93x
2025-07-154.89x
2025-07-144.93x
2025-07-114.94x
2025-07-105.01x
2025-07-094.97x
2025-07-084.98x
2025-07-074.98x
2025-07-034.99x
2025-07-024.97x
2025-07-014.97x
2025-06-305.01x
2025-06-274.95x
2025-06-264.97x
2025-06-255.01x
2025-06-244.97x
2025-06-234.94x
2025-06-204.92x
2025-06-184.87x
2025-06-174.85x
2025-06-164.88x
2025-06-134.84x
2025-06-124.89x

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About ResMed Inc.

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

San Diego, CA
9,980 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael J. Farrell